Pineamin: polycystic-ovary syndrome use — RU2732688C1
Алла Николаевна Мальцева · 2020 · RU2732688C1 · patent family 72922335
Published 2020-09-22.
Reported patent results
Reported findings
The patent reports menstrual recovery and subsequent pregnancies in two selected cases.
Two uncontrolled PCOS/infertility case examples after a three-month Pineamin course.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Case 1: gonadotropins | LH 14.2 → 6.6 IU/L; FSH 4.8 → 16.4 IU/L | One 25-year-old patient; timing within the cycle is not standardized in the report · After 3 months |
| Case 1: reproductive outcome | Cycle restoration, corpus luteum on ultrasound and pregnancy reported | Pregnancy is an individual case outcome; no live-birth result given · Second month after treatment |
| Case 2: reproductive outcome | Regular cycles, 10 mm endometrium and a 21 mm dominant follicle; uterine pregnancy reported | One 26-year-old patient; no untreated comparator · Fourth month from treatment, as worded in the patent |
| Reported tolerability | No side effects reported in the two examples | No systematic safety denominator beyond these cases |
Selected cases do not establish a pregnancy rate, PCOS cure or causality. Hormone units and the stated LH/FSH ratio contain inconsistencies, so no corrected ratio is inferred.
Source for the extracted data ↗ · Checked 2026-11-06
Patent claims and provenance
Use. The method patent proposes Pineamin in a PCOS treatment context.
Patent case examples do not establish a randomized fertility effect or make the pineal extract equivalent to synthetic Epitalon.
- Publication
- RU2732688C1 ↗ · 2020-09-22
- Earliest priority / filing
- 2020-02-06 / 2020-02-06
- Original applicant / assignee
- федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет Министерства здравоохранения Российской Федерации
- Indexed status
- Not shown; official status unverified · checked 2026-11-06
- Patent family
- 72922335 · family publications are related filings, not independent studies.
Original title, inventors and related publications
Method of treating polycystic ovary syndrome with non-hormonal preparations
Inventors: Алла Николаевна Мальцева.
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- Patent case examples do not establish a randomized fertility effect or make the pineal extract equivalent to synthetic Epitalon.
- Selected cases do not establish a pregnancy rate, PCOS cure or causality. Hormone units and the stated LH/FSH ratio contain inconsistencies, so no corrected ratio is inferred.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; the record gives its source-check date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original patent text and indexed metadata
Review depth: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related-report group: patent-family-72922335. Reports in this group are not assumed to be independent trials.
Source access and review scope
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Recorded source-check date: 2026-11-06. This date does not imply a completed systematic review.
Source type: Patent publication
Citation and original source
Original source: Алла Николаевна Мальцева. Pineamin: polycystic-ovary syndrome use — RU2732688C1 RU2732688C1 · patent family 72922335 2020.
Molekul research summary: https://molekul.io/research/patent-ru2732688c1. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry